Shanghai Kaibao Pharmaceutical (300039.SZ) Earnings Analysis
Shanghai Kaibao Pharmaceutical (300039.SZ) has no confirmed upcoming earnings date. Trailing P/E 22.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300039.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300039.SZ. This page updates as the calendar is published.
300039.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.06223 CNY | n/a | n/a | n/a |
| 2025-06-05 | 0.03601 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0806 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.1516 CNY | n/a | n/a | n/a |
| 2024-09-28 | 0.07163 CNY | n/a | n/a | n/a |
300039.SZ valuation and analyst view
| Trailing P/E | 22.41 |
|---|---|
| Trailing EPS | 0.24771 CNY |
| Price / book | 1.24 |
| Dividend yield | 2.34% |
| Market cap | 6.02B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Kaibao Pharmaceutical (300039.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300039.SZ. This page updates as the calendar is published.
Did 300039.SZ beat earnings last quarter?
Consensus estimate data was not available for 300039.SZ's 2025-09-29 report.
What is 300039.SZ's current P/E ratio and EPS?
300039.SZ trades at a trailing P/E of 22.41 on trailing EPS of 0.2477072352439715 CNY.
What do analysts rate 300039.SZ?
300039.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.